by David Grant | Jan 26, 2011
How do newspaper articles portray stem cell tourism? A research team at the University of Alberta recently asked this question, and their results were published last month in the journal Nature. Their conclusions were both surprising, and hopeful. The team, led by...
by Chris Kamel | Jan 24, 2011
Although tumours are typically thought of as a single entity, the cells that make up a tumour are genetically diverse. The traditional view of cancer progression — in which a tumour arises from a single cell after accumulated mutations — suggests that...
by Michelle Ly | Dec 20, 2010
Stem cells were high on the list of hot topics at this year’s American Society of Hematology conference in Orlando, Florida, particularly regarding the uses and effects of stem cells in the treatment of disease. The Ham-Wasserman lecture, named for two past ASH...
by Chris Kamel | Dec 9, 2010
Induced pluripotent stem (iPS) cells are generally created by the expression of a small number of key genes to reprogram adult cells into an undifferentiated, pluripotent state. Because some of the transcription factors used for reprogramming are oncogenes, as well as...
by David Kent | Dec 7, 2010
My last post was mostly centred on the lack of openness displayed by a growing number of scientists, but failed to comment on the wonderful array of findings that were presented by world leaders in stem cell biology. The Royal Society Meeting that took place in...
by Paul Krzyzanowski | Nov 17, 2010
In a previous post, Chris Kamel recently reviewed the Nature article about direct creation of blood progenitors from skin fibroblasts as discovered by Mick Bhatia’s research group. The fascinating thing about this article is the potential for enabling autologous...
Comments